Cargando…

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse

Quinoline-3-carboxamides (Q compounds) are immunomodulatory compounds that have shown efficacy both in autoimmune disease and cancer. We have in here investigated the impact of one such compound, paquinimod, on the development of diabetes in the NOD mouse model for type I diabetes (T1D). In cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tahvili, Sahar, Törngren, Marie, Holmberg, Dan, Leanderson, Tomas, Ivars, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942776/ https://www.ncbi.nlm.nih.gov/pubmed/29742113 http://dx.doi.org/10.1371/journal.pone.0196598

Ejemplares similares

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)

The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
por: Fransén Pettersson, Nina, et al.
Publicado: (2018)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
por: Hesselstrand, Roger, et al.
Publicado: (2021)

S100A9 and tumor growth
por: Leanderson, Tomas, et al.
Publicado: (2012)

Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe
por: Björk, Per, et al.
Publicado: (2013)

The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)

The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022)

Novel Mode of Defective Neural Tube Closure in the Non-Obese Diabetic (NOD) Mouse Strain
por: Salbaum, J. Michael, et al.
Publicado: (2015)

Glibenclamide Prevents Diabetes in NOD Mice
por: Lamprianou, Smaragda, et al.
Publicado: (2016)

Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice
por: Parsa, Roham, et al.
Publicado: (2012)

Human S100A9 Protein Is Stabilized by Inflammatory Stimuli via the Formation of Proteolytically-Resistant Homodimers
por: Riva, Matteo, et al.
Publicado: (2013)

CD11b(+)Ly6C(++)Ly6G(-) cells show distinct function in mice with chronic inflammation or tumor burden
por: Källberg, Eva, et al.
Publicado: (2012)

Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model
por: Virostko, John, et al.
Publicado: (2013)

Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren’s syndrome
por: Inoue, Hiroko, et al.
Publicado: (2016)

Genetic Analysis of Substrain Divergence in Non-Obese Diabetic (NOD) Mice
por: Simecek, Petr, et al.
Publicado: (2015)

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice
por: Funda, David P., et al.
Publicado: (2018)

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse
Publicado: (1987)

Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund's Adjuvant
por: Lee, Jong-Uk, et al.
Publicado: (2021)

Author Correction: Novel mode of defective neural tube closure in the non-obese diabetic (NOD) mouse strain
por: Salbaum, J. Michael, et al.
Publicado: (2022)

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
por: Funda, David P., et al.
Publicado: (2019)

Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice
por: Sodré, Fernanda M.C., et al.
Publicado: (2021)

Corrigendum to “Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund's Adjuvant”
por: Lee, Jong-Uk, et al.
Publicado: (2021)

The Impact of Diet Wheat Source on the Onset of Type 1 Diabetes Mellitus—Lessons Learned from the Non-Obese Diabetic (NOD) Mouse Model
por: Gorelick, Jonathan, et al.
Publicado: (2017)

Bisphenol S Modulates Type 1 Diabetes Development in Non-Obese Diabetic (NOD) Mice with Diet- and Sex-Related Effects
por: Xu, Joella, et al.
Publicado: (2019)

Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
por: Malek Abrahimians, Elin, et al.
Publicado: (2016)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
por: Li, Shiri, et al.
Publicado: (2021)

Effect of FTY720 on Some Physiological Indexes of Non-Obese Diabetic (NOD) Mice
por: Chen, Xiaoqiang, et al.
Publicado: (2012)

Gluten-Free Diet Only during Pregnancy Efficiently Prevents Diabetes in NOD Mouse Offspring
por: Antvorskov, Julie C., et al.
Publicado: (2016)

TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
por: Cao, Hui, et al.
Publicado: (2015)

High‐fat diet prevents the development of autoimmune diabetes in NOD mice
por: Clark, Amy L., et al.
Publicado: (2021)

The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
por: Borg, Danielle J., et al.
Publicado: (2017)

CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes
por: He, Zhifei, et al.
Publicado: (2016)

Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
por: Malek Abrahimians, Elin, et al.
Publicado: (2018)

Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice
por: Alkan, Manal, et al.
Publicado: (2015)

Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
por: Wang, Xin, et al.
Publicado: (2012)

Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse
por: Carrero, Javier A., et al.
Publicado: (2013)

DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod
por: Talley, Sarah, et al.
Publicado: (2021)

Prevention of Cyclophosphamide-induced Accelerated Diabetes in the NOD Mouse by Nicotinamide or a Soy Protein-based Infant Formula
por: Reddy, S., et al.
Publicado: (2000)

Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes
por: Rodrigues e-Lacerda, Rodrigo, et al.
Publicado: (2023)

Knockout of the Amino Acid Transporter SLC6A19 and Autoimmune Diabetes Incidence in Female Non-Obese Diabetic (NOD) Mice
por: Waters, Matthew F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bckaq9de9appfr3ulpbv525vs8